TOPLINE:
Regular use of glucosamine, a widely used supplement to manage osteoarthritis and joint pain, was linked to reduced risks for both composite microvascular complications and diabetic nephropathy among patients with type 2 diabetes (T2D).
METHODOLOGY:
- Glucosamine, used daily by about 20% of US and Australian adults to treat osteoarthritis and joint pain, has been shown to reduce the risk for certain diseases, including T2D, and to have a mild glucose-lowering effect.
- Researchers evaluated the association between habitual glucosamine use and the risk for three diabetic microvascular complications in people with T2D from the UK Biobank who did not have microvascular complications at the time of enrollment.
- Overall, 14.5% of the 21,171 participants (mean age, 57 years; 43% women) reported using glucosamine at…